Off-the-Shelf mRNA Products
Our ready-to-use mRNA products are meticulously engineered for robust expression in transfection and screening workflows.
Key Features and Benefits:
- Ready for Expression: All mRNA products are fully processed – capped polyadenylated and offered with modifications such as N1-methyl-pseudo-Uridine to reduce innate immune activation. This ensures rapid translation in cells or animal models.
- Variety and Convenience: Choose from a diverse range of fluorescent and luminescent reporter mRNA products—all available off the shelf in experiment-sized or bulk quantities.
- Validation: Each catalog mRNA product is thoroughly validated for consistency, and available with or without modified bases to suit different research requirements.
Optimizing Delivery: LNP Sampler Kits
Accelerate your research by using PackGene’s LNP sampler kits. These kits are designed to help you identify the optimal lipid nanoparticle (LNP) system for your specific application.
- Kit Contents: Each kit includes EGFP or Firefly luciferase reporter mRNA products encapsulated in four distinct LNP formulations. Empty LNPs are also included as negative controls for rigorous control and data interpretation.
Key Features and Benefits:
- Performance Benchmarking: Assess transfection efficiency and gene expression using our fully processed, ready-to-use reporter mRNA products across top LNP systems.
- Versatility: Kits include both EGFP and Firefly luciferase mRNA products, enabling fluorescence or luminescence readouts for flexible experimental design and sensitive detection.
- Regulatory-Ready Quality: All mRNA products in our LNP sample kits incorporate N1-methyl-pseudo-Uridine modification to minimize innate immune response, supporting downstream translational and preclinical applications.
- Rapid Delivery: In-stock mRNA products and LNP sample kits ship within 1–3 business days for quick project turnaround.
Performance
-
Efficacy of our mRNA products and delivery systems tested and confirmed through experimental data
EGFP mRNA-LNP (SM-102) transduction in Huh7 cell line, showing expression at 24hr, 48hr, and 72hr for Cap 1 EGFP and modified Cap 1 N1meΨ EGFP, compared to a negative control (NC).
The modified (Cap 1 N1meΨ EGFP) mRNA products demonstrate robust and sustained expression across all time points, supporting their use in gene editing or in vivo animal models.
EGFP mRNA-LNP(SM-102)
Huh7 cell line transduction
